US Biomax, Inc.

SM802

Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases/80 cores

Microarray Panel:Small intestine disease spectrum (small intestine carcinoma progression) tissue microarray, containing 46 cases of small intestine adenocarcinoma, 8 metastatic carcinoma, 3 each of ulcer and hyperplasia, 5 each of adjacent tissue, inflammation, adjacent normal tissue and normal tissue, single core per case
Cores:80
Cases:72
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Sma Sma Sma Sma Sma Sma Sma Sma Sma Sma  
B Sma Sma Sma Sma Sma Sma Sma Sma Sma Sma  
C Sma Sma Sma Sma Sma Sma Sma Sma Sma Sma  
D Sma Sma Sma Sma Sma Sma Sma Sma Sma Sma  
E Sma Sma Sma Sma Sma Sma Ome Lym Lym Lym  
F Lym Lym Lym Lym Sma Sma Sma Sma Sma Sma  
G Sma Sma Sma Sma Sma Sma Sma Sma Sma Sma  
H Sma Sma Sma Sma Sma Sma Sma Sma Sma Sma Marked point
Legend: Lym - Lymph node, Ome - Omentum, Sma - Small intestine

- Adjacent, - Hyperplasia, - Inflammation, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Metastasis, - NAT, - Normal tissue, - Ulcer

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 50 Small intestine Mucinous adenocarcinoma 1 II T3N0M0 Malignant
A2 2 F 45 Small intestine Adenocarcinoma with necrosis 1 II T3N0M0 Malignant
A3 3 M 48 Small intestine Adenocarcinoma 1 I T2N0M0 Malignant
A4 4 M 72 Small intestine Adenocarcinoma 1 I T1N0M0 Malignant
A5 5 M 52 Small intestine Adenocarcinoma 1 I T2N0M0 Malignant
A6 6 M 73 Small intestine Adenocarcinoma 1 I T2N0M0 Malignant
A7 7 F 55 Small intestine Adenocarcinoma 1 II T3N0M0 Malignant
A8 8 F 72 Small intestine Adenocarcinoma 1 II T3N0M0 Malignant
A9 9 F 40 Small intestine Adenocarcinoma 1 I T2N0M0 Malignant
A10 10 M 60 Small intestine Adenocarcinoma 1 II T4N0M0 Malignant
B1 11 M 50 Small intestine Adenocarcinoma 1 II T3N0M0 Malignant
B2 12 M 43 Small intestine Adenocarcinoma 1 II T4N0M0 Malignant
B3 13 F 38 Small intestine Adenocarcinoma 1 II T4N0M0 Malignant
B4 14 F 49 Small intestine Adenocarcinoma 1 II T4N0M0 Malignant
B5 15 M 66 Small intestine Adenocarcinoma 1 II T3N0M0 Malignant
B6 16 M 51 Small intestine Adenocarcinoma 2 II T4N0M0 Malignant
B7 17 F 52 Small intestine Adenocarcinoma 2 II T4N0M0 Malignant
B8 18 F 69 Small intestine Adenocarcinoma 1 II T3N0M0 Malignant
B9 19 M 73 Small intestine Adenocarcinoma 1 II T4N0M0 Malignant
B10 20 F 65 Small intestine Adenocarcinoma 1 II T3N0M0 Malignant
C1 21 F 48 Small intestine Adenocarcinoma 2 II T4N0M0 Malignant
C2 22 M 60 Small intestine Adenocarcinoma 2 II T3N0M0 Malignant
C3 23 M 57 Small intestine Adenocarcinoma 2 II T3N0M0 Malignant
C4 24 M 60 Small intestine Adenocarcinoma 2 I T2N0M0 Malignant
C5 25 M 58 Small intestine Adenocarcinoma 1 I T2N0M0 Malignant
C6 26 F 64 Small intestine Adenocarcinoma 2 II T4N0M0 Malignant
C7 27 M 48 Small intestine Adenocarcinoma 2–3 I T2N0M0 Malignant
C8 28 M 69 Small intestine Adenocarcinoma 2 II T4N0M0 Malignant
C9 29 M 63 Small intestine Adenocarcinoma 2 II T4N0M0 Malignant
C10 30 M 43 Small intestine Adenocarcinoma 2 II T3N0M0 Malignant
D1 31 M 43 Small intestine Adenocarcinoma (sparse) 2 II T4N0M0 Malignant
D2 32 F 49 Small intestine Mucinous adenocarcinoma 2 II T4N0M0 Malignant
D3 33 M 45 Small intestine Adenocarcinoma 2 II T4N0M0 Malignant
D4 34 M 69 Small intestine Adenocarcinoma 2–3 II T3N0M0 Malignant
D5 35 F 65 Small intestine Adenocarcinoma 2 II T3N0M0 Malignant
D6 36 M 69 Small intestine Adenocarcinoma 2 I T2N0M0 Malignant
D7 37 F 64 Small intestine Mucinous adenocarcinoma 3 II T4N0M0 Malignant
D8 38 M 52 Small intestine Adenocarcinoma 2 III T3N1M0 Malignant
D9 39 F 50 Small intestine Adenocarcinoma 2 II T4N0M0 Malignant
D10 40 M 65 Small intestine Adenocarcinoma 3 II T4N0M0 Malignant
E1 41 M 74 Small intestine Adenocarcinoma 3 II T4N0M0 Malignant
E2 42 F 35 Small intestine Adenocarcinoma (fibrofatty tissue) II T4N0M0 Malignant
E3 43 M 72 Small intestine Adenocarcinoma 3 II T3N0M0 Malignant
E4 44 M 42 Small intestine Adenocarcinoma 3 II T4N0M0 Malignant
E5 45 M 39 Small intestine Adenocarcinoma 3 III T3N1M0 Malignant
E6 46 M 42 Small intestine Adenocarcinoma with necrosis 2–3 II T3N0M0 Malignant
E7 47 M 48 Omentum Metastatic adenocarcinoma from duodenum 2 Metastasis
E8 48 M 67 Lymph node Metastatic adenocarcinoma from duodenum beyond serosa of No. 69 3 Metastasis
E9 49 M 45 Lymph node Metastatic adenocarcinoma from duodenum of omentum of No. 33 3 Metastasis
E10 50 F 52 Lymph node Metastatic adenocarcinoma from duodenum 3 Metastasis
F1 51 M 52 Lymph node Metastatic adenocarcinoma from small intestine with necrosis of omentum of No. 38 3 Metastasis
F2 52 M 72 Lymph node Metastatic adenocarcinoma from duodenum of mesentery 3 Metastasis
F3 53 F 59 Lymph node Metastatic adenocarcinoma from small intestine beyond serosa 3 Metastasis
F4 54 F 62 Lymph node Metastatic adenocarcinoma from small intestine of mesentery 3 Metastasis
F5 55 F 39 Small intestine Ulcer Ulcer
F6 56 M 50 Small intestine Ulcer of duodenum Ulcer
F7 57 M 58 Small intestine Ulcer Ulcer
F8 58 M 38 Small intestine Adenomatoid hyperplasia Hyperplasia
F9 59 M 58 Small intestine Hyperplasia of mucosa Hyperplasia
F10 60 F 57 Small intestine Hyperplasia of mucosa (fibrous tissue and blood vessel) Hyperplasia
G1 61 M 42 Small intestine Cancer adjacent tissue (chronic inflammation) of No. 46 AT
G2 62 M 57 Small intestine Cancer adjacent tissue (smooth muscle) of No. 23 AT
G3 63 M 66 Small intestine Cancer adjacent tissue of No. 15 AT
G4 64 M 69 Small intestine Cancer adjacent tissue (chronic inflammation) of No. 34 AT
G5 65 F 64 Small intestine Cancer adjacent tissue (chronic inflammation) of No. 37 AT
G6 66 M 58 Small intestine Chronic inflammation Inflammation
G7 67 M 70 Small intestine Chronic inflammation Inflammation
G8 68 F 55 Small intestine Mild chronic inflammation Inflammation
G9 69 M 67 Small intestine Mild chronic inflammation Inflammation
G10 70 M 62 Small intestine Mild chronic inflammation Inflammation
H1 71 M 31 Small intestine Cancer adjacent normal small intestine tissue NAT
H2 72 F 39 Small intestine Cancer adjacent normal small intestine tissue NAT
H3 73 F 56 Small intestine Cancer adjacent normal small intestine tissue NAT
H4 74 F 36 Small intestine Cancer adjacent normal small intestine tissue NAT
H5 75 F 50 Small intestine Cancer adjacent normal small intestine tissue NAT
H6 76 M 35 Small intestine Normal small intestine tissue Normal
H7 77 F 38 Small intestine Normal small intestine tissue Normal
H8 78 M 35 Small intestine Normal small intestine tissue Normal
H9 79 M 30 Small intestine Normal small intestine tissue Normal
H10 80 M 25 Small intestine Normal small intestine tissue Normal
M 58 Skin Malignant melanoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: